Showing results 6 to 9 of 9
< previous
| Issue Date | Title | Author(s) |
| 2013 | Economic modelling of diagnostic and treatment pathways in National Institute for Health and Care Excellence clinical guidelines: the Modelling Algorithm Pathways in Guidelines (MAPGuide) project | Lord, J; Willis, S; Eatock, J; Tappenden, P; Trapero-Bertran, M; Miners, A; Crossan, C; Westby, M; Anagnostou, A; Taylor, SJE; Mavranezouli, I; Wonderling, D; Alderson, P; Ruiz, F |
| 2013 | Economic modelling of diagnostic and treatment pathways in NICE clinical guidelines: the MAPGuide project | Lord, J; Willis, S; Eatock, J; Tappenden, P; Trapero-Bertran, M; Miners, A; Crossan, C; Westby, M; Anagnostou, A; Taylor, S; Mavranezouli, I; Wonderling, D; Alderson, P; Ruiz, F |
| 2015 | Edoxaban for preventing stroke and systemic embolism in people with non-valvular atrial fibrillation: A Single Technology Appraisal. Evidence Review Group Report to NICE | Greenhalgh, J; Longworth, L; Crossan, C; Singh, J; Bagust, A; Beale, S; Richardson, M; Banks, L; Kotas, E; Hall, M |
| 14-Mar-2018 | A Protocol for an economic evaluation of a polypill in patients with established or at high risk of cardiovascular disease in a UK NHS setting: RUPEE (NHS) study | Crossan, C; Dehbi, HM; Williams, H; Poulter, N; Rodgers, A; Jan, S; Thom, S; Lord, J |
